Meropen and hepatic failure Patient Reports February 10, 2010
Meropen Side Effects Report #5191430-1
Meropen side effect was reported by a Health Professional from JAPAN on Dec 06, 2006. Male patient, 75 years of age, weighting 110.2 lb, was diagnosed with sepsis
, disseminated intravascular coagulation, pneumonia
, cholangitis, lung disorder and was treated with Meropen. After drug was administered, patient experienced the following side effects: cholangitis, hepatic failure, hepatitis
, jaundice cholestatic, respiratory failure. Meropen dosage: unknown. During the same period patient was treated with CARBENIN, NEUART, PENTOCILLIN, MAXIPIME, ELASPOL. Patient died.Meropen Side Effects Report #5920779-7
Meropen side effect was reported by a Health Professional from JAPAN on Oct 17, 2007. Male patient, 75 years of age, weighting 110.2 lb, was diagnosed with sepsis
, disseminated intravascular coagulation, pneumonia
, cholangitis, lung disorder and was treated with Meropen. After drug was administered, patient experienced the following side effects: cholangitis, hepatic failure, hepatitis
, rash
. Meropen dosage: unknown. During the same period patient was treated with CARBENIN, NEUART, PENTOCILLIN, MAXIPIME, ELASPOL. Patient died.Meropen Side Effects Report #4826307-1
Meropen side effect was reported by a Health Professional from JAPAN on Aug 03, 2005. Male patient, 79 years of age, was diagnosed with pneumonia
, gastrointestinal haemorrhage, cardiac failure and was treated with Meropen. After drug was administered, patient experienced the following side effects: ascites, hepatic atrophy, hepatic failure, hepatitis fulminant, hepatocellular damage, upper gastrointestinal haemorrhage. Meropen dosage: unknown. During the same period patient was treated with GASTER, LASIX. Patient died on 06/08/2005.Meropen Side Effects Report #4655091-X
Meropen side effect was reported by a Consumer or non-health professional from on Feb 16, 2005. Male patient, 62 years of age, weighting 100.3 lb, was diagnosed with cellulitis
, pruritus and was treated with Meropen. After drug was administered, patient experienced the following side effects: agitation, blood pressure decreased, coma hepatic, condition aggravated, disseminated intravascular coagulation, hepatic failure, hepatitis fulminant, hypoglycaemia, pneumonia
. Meropen dosage: unknown. During the same period patient was treated with BROACT, SEDIEL, CLINORIL, CALCIUM CARBONATE, BAYASPIRIN, PROTECADIN, INDERAL LA. Patient died on 12/11/2004.
Meropen and hepatic failure 